Ulrich Jaeger

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (17)

Lisa Schneider

Medical University of Vienna

AUSTRIA

View details

Edmund K. Waller

Professor

Winship Cancer Institute of Emory University

UNITED STATES

View details

Lorenz Schubert

Medical University of Vienna

AUSTRIA

View details

Constantine S. Tam

AUSTRALIA

View details

Peter Riedell

University of Chicago

UNITED STATES

View details

Michael A. Pulsipher

UNITED STATES

View details

Stephan Blüml

Medical University of Vienna

AUSTRIA

View details

Tae Min Kim

Seoul National University Hospital

SOUTH KOREA

View details

Adam Olszewski

Associate Professor of Medicine

Rhode Island Hospital

UNITED STATES

View details

Christian Schoergenhofer

Medical University of Vienna

AUSTRIA

View details

Judith H. Aberle

AUSTRIA

View details

Bernd Jilma

Full Professor

Medical University of Vienna

AUSTRIA

View details

Klaus Podar

Consultant/ Head Division Molecular Oncology and Hematology

Karl Landsteiner University of Health Sciences

AUSTRIA

View details

Amitkumar Mehta

Assistant professor

The University of Alabama

UNITED STATES

View details

Tycel Phillips

University of Michigan Medical School

UNITED STATES

View details

Charalambos Andreadis

University of California, San Francisco

UNITED STATES

View details

Nina Worel

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ulrich Jaeger

Research Interests

Explore related searches

Contact this professor

Articles (11)

Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study

Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease

Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination—A Retrospective Cohort Study

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination

Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma

Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab

How I manage autoimmune cytopenias in patients with lymphoid cancer

Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma

In Human Visualization of Ibrutinib-Induced CLL Compartment Shift

Collaborators (17)

Lisa Schneider

Edmund K. Waller

Lorenz Schubert

Constantine S. Tam

Peter Riedell

Michael A. Pulsipher

Stephan Blüml

Tae Min Kim

Adam Olszewski

Christian Schoergenhofer

Judith H. Aberle

Bernd Jilma

Klaus Podar

Amitkumar Mehta

Tycel Phillips

Charalambos Andreadis

Nina Worel

Make your next move.